BioCentury | Nov 20, 2019
Financial News

Werewolf debuts with $56M to develop tumor-activated biologics

...have technologies that aim to deliver immuno-modulators that are conditionally activated in the tumor microenvironment. Maverick Therapeutics Inc....
BioCentury | Aug 8, 2019
Emerging Company Profile

Akrevia: Masking immunotherapies en route to tumors

...use specific physiological and metabolic conditions found in the tumor microenvironment to activate their compounds. Maverick Therapeutics Inc....
...Duarte, Calif. Cybrexa Therapeutics Inc., New Haven, Conn. CytomX Therapeutics Inc., South San Francisco, Calif. Maverick Therapeutics Inc....
...IL-2 - Interleukin-2 Inhua Muijrers-Chen, Associate Editor Akrevia Therapeutics LLC BioAtla LLC BlinkBio Inc. City of Hope Cybrexa Therapeutics Inc. CytomX Therapeutics Inc. Maverick Therapeutics Inc. Cytotoxic...
BioCentury | Aug 2, 2019
Company News

Aug. 1 Management tracks: R&D chief leaving Adaptimmune; plus Frontier Medicines builds out team and more

...emerging markets at the Bioverativ Inc. unit of Sanofi (Euronext:SAN; NASDAQ:SNY). T cell therapy company Maverick Therapeutics Inc....
...Society of America. Jonathan Block, Associate Editor Adaptimmune Therapeutics plc Canbridge Pharmaceuticals Inc. Endo International plc Frontier Medicines Corp. G1 Therapeutics Inc. Maverick Therapeutics Inc. NewLink...
BioCentury | Jan 30, 2019
Company News

Management tracks: Corvus, Maverick

...director and the venetoclax development lead at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). Maverick Therapeutics Inc....
...Xtera Ltd. Pankhania succeeds Richard Vellacott as CFO. Elizabeth S. Eaton Corvus Pharmaceuticals Inc. GigaGen Inc. Horizon Discovery Group plc Maverick Therapeutics Inc. PolarityTE...
BioCentury | Aug 10, 2018
Finance

Takeda gets Ambys-tious

...Jeffrey Tong, Ambys Less than a week later on Jan. 11, 2017, Takeda partnered with Maverick Therapeutics Inc....
...ideas.” Companies and Institutions Mentioned Ambys Medicines, Redwood City, Calif. GammaDelta Therapeutics Ltd., London, U.K. Maverick Therapeutics Inc....
BioCentury | Oct 6, 2017
Financial News

Cullinan raises $150M in series A

...cancer start-ups, including Harpoon Therapeutics Inc. (South San Francisco, Calif.), iOmx Therapeutics AG (Martinsreid, Germany), Maverick Therapeutics Inc....
BioCentury | Oct 3, 2017
Financial News

Cullinan raises $150M series A round

...cancer start-ups, including Harpoon Therapeutics Inc. (South San Francisco, Calif.), iOmx Therapeutics AG (Martinsreid, Germany), Maverick Therapeutics Inc....
BioCentury | Aug 17, 2017
Finance

Built to purpose

...a 2014 IPO. MPM has created seven build-to-buys. Most recently, it partnered with Takeda on Maverick Therapeutics Inc....
...San Diego, Calif. Inception 3 Inc., San Diego, Calif. Iron Horse Therapeutics, San Diego, Calif. Maverick Therapeutics Inc....
BioCentury | Aug 11, 2017
Company News

Management tracks: Orchard, Maverick, Pieris

...CEO. He was chief commercial officer at PTC Therapeutics Inc. (NASDAQ:PTCT). T cell therapy company Maverick Therapeutics Inc....
BioCentury | Jun 22, 2017
Product R&D

Bispecific redirection

...to stake new territory in the field. Through Harpoon Therapeutics Inc. and the recently launched Maverick Therapeutics Inc....
...applications filed by Harpoon Therapeutics Inc. Patent application filed Company; lead investigator Harpoon Therapeutics Inc. Maverick Therapeutics Inc....
...CytomX Therapeutics Inc. (NASDAQ:CTMX), South San Francisco, Calif. Harpoon Therapeutics Inc., South San Francisco, Calif. Maverick Therapeutics Inc....
Items per page:
1 - 10 of 18
BioCentury | Nov 20, 2019
Financial News

Werewolf debuts with $56M to develop tumor-activated biologics

...have technologies that aim to deliver immuno-modulators that are conditionally activated in the tumor microenvironment. Maverick Therapeutics Inc....
BioCentury | Aug 8, 2019
Emerging Company Profile

Akrevia: Masking immunotherapies en route to tumors

...use specific physiological and metabolic conditions found in the tumor microenvironment to activate their compounds. Maverick Therapeutics Inc....
...Duarte, Calif. Cybrexa Therapeutics Inc., New Haven, Conn. CytomX Therapeutics Inc., South San Francisco, Calif. Maverick Therapeutics Inc....
...IL-2 - Interleukin-2 Inhua Muijrers-Chen, Associate Editor Akrevia Therapeutics LLC BioAtla LLC BlinkBio Inc. City of Hope Cybrexa Therapeutics Inc. CytomX Therapeutics Inc. Maverick Therapeutics Inc. Cytotoxic...
BioCentury | Aug 2, 2019
Company News

Aug. 1 Management tracks: R&D chief leaving Adaptimmune; plus Frontier Medicines builds out team and more

...emerging markets at the Bioverativ Inc. unit of Sanofi (Euronext:SAN; NASDAQ:SNY). T cell therapy company Maverick Therapeutics Inc....
...Society of America. Jonathan Block, Associate Editor Adaptimmune Therapeutics plc Canbridge Pharmaceuticals Inc. Endo International plc Frontier Medicines Corp. G1 Therapeutics Inc. Maverick Therapeutics Inc. NewLink...
BioCentury | Jan 30, 2019
Company News

Management tracks: Corvus, Maverick

...director and the venetoclax development lead at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). Maverick Therapeutics Inc....
...Xtera Ltd. Pankhania succeeds Richard Vellacott as CFO. Elizabeth S. Eaton Corvus Pharmaceuticals Inc. GigaGen Inc. Horizon Discovery Group plc Maverick Therapeutics Inc. PolarityTE...
BioCentury | Aug 10, 2018
Finance

Takeda gets Ambys-tious

...Jeffrey Tong, Ambys Less than a week later on Jan. 11, 2017, Takeda partnered with Maverick Therapeutics Inc....
...ideas.” Companies and Institutions Mentioned Ambys Medicines, Redwood City, Calif. GammaDelta Therapeutics Ltd., London, U.K. Maverick Therapeutics Inc....
BioCentury | Oct 6, 2017
Financial News

Cullinan raises $150M in series A

...cancer start-ups, including Harpoon Therapeutics Inc. (South San Francisco, Calif.), iOmx Therapeutics AG (Martinsreid, Germany), Maverick Therapeutics Inc....
BioCentury | Oct 3, 2017
Financial News

Cullinan raises $150M series A round

...cancer start-ups, including Harpoon Therapeutics Inc. (South San Francisco, Calif.), iOmx Therapeutics AG (Martinsreid, Germany), Maverick Therapeutics Inc....
BioCentury | Aug 17, 2017
Finance

Built to purpose

...a 2014 IPO. MPM has created seven build-to-buys. Most recently, it partnered with Takeda on Maverick Therapeutics Inc....
...San Diego, Calif. Inception 3 Inc., San Diego, Calif. Iron Horse Therapeutics, San Diego, Calif. Maverick Therapeutics Inc....
BioCentury | Aug 11, 2017
Company News

Management tracks: Orchard, Maverick, Pieris

...CEO. He was chief commercial officer at PTC Therapeutics Inc. (NASDAQ:PTCT). T cell therapy company Maverick Therapeutics Inc....
BioCentury | Jun 22, 2017
Product R&D

Bispecific redirection

...to stake new territory in the field. Through Harpoon Therapeutics Inc. and the recently launched Maverick Therapeutics Inc....
...applications filed by Harpoon Therapeutics Inc. Patent application filed Company; lead investigator Harpoon Therapeutics Inc. Maverick Therapeutics Inc....
...CytomX Therapeutics Inc. (NASDAQ:CTMX), South San Francisco, Calif. Harpoon Therapeutics Inc., South San Francisco, Calif. Maverick Therapeutics Inc....
Items per page:
1 - 10 of 18